Panchtikhta Panchprasritiki Vasti in Madhumeha ( Diabetes Mellitus Type 2)
Not Applicable
- Conditions
- Health Condition 1: E119- Type 2 diabetes mellitus without complications
- Registration Number
- CTRI/2020/05/025211
- Lead Sponsor
- Gurukul campus
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
newly diagnosed madhumeha (diabetes mellitus type 2)
patient with hyperglycemia taking irregular medication, no medication, or mild medication.
Exclusion Criteria
patient having diabetes mellitus type 1
patient of diabetes mellitus type 2 on insulin
patient with complication like renal failure, neuropathy, etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To assess the effect of therapy,objectively all sign and symptoms were given scoring depending upon their severity: <br/ ><br>1- markedly improvement : 76-100% relief in sign and symptoms <br/ ><br>2-moderate improvement: 51-75% relief in sign and symptoms <br/ ><br>3-mild improvement:26-50% relef in sign and symptoms <br/ ><br>4-no improvement: 0-25% relef in sign and symptoms.Timepoint: At 16th day, 32th day, 48th day,62th day
- Secondary Outcome Measures
Name Time Method blood sugar fasting <br/ ><br>blood sugar pp <br/ ><br>hba1c <br/ ><br>urine examination routine <br/ ><br>urine examination microscopic <br/ ><br>hb% <br/ ><br>t.l.c, d.l.c, <br/ ><br>lipid profile <br/ ><br>lft <br/ ><br>kftTimepoint: At 16th day,32th day,48th day,62th day
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie Panchtikta Vasti's effects on insulin resistance in T2DM patients?
How does Panchtikta Panchprasritiki Vasti compare to metformin in glycemic control for E119 T2DM?
Are there specific biomarkers that predict response to Ayurvedic basti therapy in type 2 diabetes mellitus?
What adverse events are associated with Panchtikta Vasti treatment and how are they managed?
What combination therapies show synergistic effects with Ayurvedic basti in managing diabetes complications?